Nubila announces support for x402 payment protocol, ushering in a new era of AI autonomous payments
PANews, October 26 – Nubila announced that it will support the new internet payment protocol x402 and will soon announce its first strategic partner to jointly explore the integration of AI autonomous payments and the real-world data economy. The x402 protocol is based on the HTTP status code "402 Payment Required," enabling websites, AI, and APIs to autonomously make payments and settlements without the need for accounts or intermediaries—this means that in the future, AI Agents will not only be able to autonomously call data interfaces but also complete payments independently, realizing true "machine-to-machine payments." Through x402, Nubila's Weather API will become one of the world's first real-world data interfaces to support AI automatic payment access. When AI calls Nubila's weather data, it can directly pay a small amount of stablecoins (such as USDT), and contributors who provide real-world data will instantly receive on-chain rewards. Nubila stated that this move marks a key step at the intersection of "AI × DePIN × Payments," as it builds a foundational layer for the free flow of real-world data, intelligent systems, and value.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Qualcomm (QCOM.US) Snapdragon Summit Preview: 2nm Dual-Chip Debuts, AI Diversification Narrative Faces Key Verification
Qualcomm is scheduled to hold its annual Snapdragon Summit in Maui, Hawaii, from September 22 to 24 local time.
SUI SuperTrend Flips to Buy — Macro Shift From Bearish to Bullish Begins

Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"
After being surpassed by Eli Lilly in the obesity market, Novo Nordisk failed to present a concrete turnaround plan to CEO Mike Doustdal, disappointing investors. The company has pledged to launch more than five blockbuster drugs in the coming years and achieve over $23 billion in new sales, but the press conference lacked details on how to drive growth.

STONK hits new highs after erasing 27% crash

